- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 93,280 | 10.07.24 16:04:17 | +1,260 | +1,37% | 93,400 | 93,450 | 92,080 | 92,020 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 970,600 | 10.07.24 08:02:09 | -11,000 | -1,12% | 981,000 | 987,600 | 970,600 | 981,600 |
